Literature DB >> 34817862

Bullous Sweet syndrome following SARS-CoV-2 Oxford AstraZeneca vaccine.

T Žagar1, N Hlača1,2, I Brajac1,2, L Prpić-Massari1,2, S Peternel1,2, M Kaštelan1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34817862     DOI： 10.1111/bjd.20876

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  1 in total

1.  Sweet syndrome following Moderna COVID-19 vaccine: A case report.

Authors:  Frederic Pelchat; Cynthia Fournier; Emilie Perron; Martin Gilbert; Bernard Delisle
Journal:  SAGE Open Med Case Rep       Date:  2022-08-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.